Lubrizol and Polyhose have jointly inaugurated a state-of-the-art medical manufacturing facility in Chennai, Tamil Nadu. The new site strengthens India’s MedTech ecosystem by expanding local production of precision medical tubing used in minimally invasive devices.
Strategic Push into Medical Device Manufacturing
The new facility focuses on producing precision extruded medical tubing for neurovascular and cardiovascular applications. Moreover, it supports the rapid growth of India’s healthcare and medical technology sectors by improving local manufacturing capacity.
In addition, the plant enhances supply reliability for both domestic and global customers, ensuring faster access to critical medical components.
World-Class Facility with Global Standards
Designed as an ISO 13485-certified operation, the Chennai facility maintains strict quality standards aligned with Lubrizol’s global manufacturing network. Consequently, it provides customers with a consistent and reliable source of high-performance medical tubing.
The facility produces tubing using a wide range of advanced materials, including polyamides, nylon, Pebax®, polypropylene, polyethylene, and Lubrizol’s medical-grade thermoplastic polyurethane (TPU). As a result, it supports diverse device applications across the medical sector.
Leadership Emphasizes Innovation and Local Strengthening
John Valukas, President, Lubrizol Engineered Materials, highlighted the strategic importance of the launch. He stated that the facility reflects Lubrizol’s commitment to India and to advancing global medical device innovation.
He further emphasized that combining Lubrizol’s materials expertise with local manufacturing capabilities will accelerate the delivery of life-saving technologies. In addition, it will help customers bring high-quality medical devices to market faster with dependable local supply.
India Positioned as a Key Growth Hub
Abhishek Shrivastava, Managing Director, Lubrizol IMEA, noted that India remains a strategic growth market for the company. He explained that the Chennai facility strengthens a broader ecosystem of manufacturing, R&D, and technical services.
Furthermore, he added that the collaboration with Polyhose will foster innovation, generate skilled employment, and reinforce India’s role in the global medical device supply chain.
Advancing Minimally Invasive Medical Technologies
Mittal Shah, Business Head, Medical Devices IMEA at Lubrizol, emphasized that minimally invasive procedures are transforming patient care. Therefore, high-precision tubing plays a critical role in enabling these advanced devices.
He noted that the Chennai facility brings catheter tubing capabilities closer to customers across India and the IMEA region. Consequently, it will enhance collaboration with medical device OEMs throughout the product development lifecycle.
As per the press release, the new manufacturing site significantly expands India’s capacity for precision extruded medical tubing. In turn, this contributes to national efforts aimed at strengthening domestic medical device manufacturing and reducing import dependence.
Moreover, the facility improves patient access to safe, high-quality medical products by reinforcing local production capabilities.
Polyhose Highlights Collaboration and Future Vision
Shabbir Yusuf Jamnagarwala, Founder and Managing Director of Polyhose, described the partnership as a major milestone in the company’s journey. He explained that combining Polyhose’s extrusion expertise with Lubrizol’s materials science capabilities enables the delivery of advanced medical tubing solutions.
Additionally, he stressed that the investment reflects a long-term commitment to innovation, skilled job creation, and India’s emergence as a trusted global hub for medical device manufacturing.
Conclusion
Overall, the Chennai facility marks a significant step forward for India’s MedTech sector. By combining global expertise with local manufacturing strength, Lubrizol and Polyhose are not only enhancing supply chain resilience but also accelerating the development of next-generation medical technologies.
